Arizona Capitol Reports Staff//March 30, 2009//[read_meter]

Federal legislation that would expedite the arrival of generic versions of biotechnology drugs onto the market has stirred up controversy in the Senate and among the nation's biotech firms. Senators...

Get 24/7 political news coverage and access to events honoring top political professionals

Tags: Breaking News

Upcoming Event

Federal legislation would foster competition among pharmaceutical firms

Federal legislation would foster competition among pharmaceutical firms

Get 24/7 political news coverage and access to events honoring top political professionals

Subscribe

Recent News

Redistricting expert projects Arizona to gain seat in Congress

Peggy Judd: Just here to do her job

Corp Comm upholds contentious APS solar charge

Tax relief renters’ gain, cities’ loss

Trump taps immigration hard-liner Kari Lake as head of Voice of America

Commission sends Hobbs candidates for her Supreme Court justice appointment

NEWSLETTER